Form 4: Ideaya Biosciences' Chief Scientific Officer Executes Stock Option and Sells Shares

Michael Anthony White, Chief Scientific Officer of Ideaya Biosciences, exercised stock options and sold shares on May 29, 2024, according to a recent SEC filing.

Summary

• On May 29, 2024, Michael Anthony White, the Chief Scientific Officer of Ideaya Biosciences, exercised stock options to acquire 28,500 shares of common stock at a price of $12.86 per share.
• Simultaneously, White sold 28,500 shares of common stock in two separate transactions at weighted average prices of $36.2251 and $36.7763.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 22, 2024.
• Following these transactions, White holds zero shares of common stock directly and 64,000 derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the trades mitigates any significant concerns.

Key Dates